71 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
, insurance companies, and certain other financial institutions;
U.S. expatriates and certain former citizens or long-term residents of the United States … or other taxable disposition of ordinary shares or ADSs will be capital gain or loss, and will be long-term capital gain or loss if the U.S.
S-29
8-K
EX-1.1
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Centessa Pharmaceuticals Announces $150,000,000 Proposed Public Offering of American Depositary Shares
4:00pm
) there has not been any material change in the share capital, short-term debt or long-term debt of the Company and its subsidiaries, taken as a whole.
(y
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
, and certain other financial institutions;
U.S. expatriates and certain former citizens or long-term residents of the United States;
dealers or traders … disposition of ordinary shares or ADSs will be capital gain or loss, and will be long-term capital gain or loss if the U.S.
S-29
Holder held the ordinary
S-3ASR
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Automatic shelf registration
4:01pm
in the long-term, (ii) the interests of the company’s employees,(iii) the need to foster the company’s business relationships with suppliers, customers
8-K
EX-99.1
bm5f19l3o8r3azr
13 Aug 24
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for Anticipated Upcoming Program Milestones
7:15am
DEFA14A
02x8pw1ods
20 May 24
Additional proxy soliciting materials
8:48pm
8-K
EX-99.1
pvs3xx927rvo l0k8fv
13 May 24
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for Anticipated Upcoming Program Milestones
4:23pm
PRE 14A
iuqmnq7y1h5e0ufexe7
26 Apr 24
Preliminary proxy
4:36pm
424B5
ibljfu220
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
EX-1.1
mhhlnvv7l39ly6nw kg
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
t3l8m0ow ne2
23 Apr 24
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
onsncu
28 Mar 24
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
4:35pm
8-K
EX-99.2
1xax icxwfw65p
11 Dec 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
bdr0p5heebwa75
13 Nov 23
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2023
4:17pm